Global Food Allergy Treatment Market Insights Forecasts to 2033

• The Global Food Allergy Treatment Market Size was Valued at USD 5.67 Billion in 2023
• The Market Size is Growing at a CAGR of 9.27% from 2023 to 2033
• The Worldwide Food Allergy Treatment Market Size is Expected to Reach USD 13.76 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Food Allergy Treatment Market Size is Anticipated to Exceed USD 13.76 Billion by 2033, Growing at a CAGR of 9.27% from 2023 to 2033.

Market Overview

A food allergy occurs when the body's immune system responds improperly to an external agent. When allergies occur, the body exhibits mild to severe symptoms. The primary driver of the market's expansion over the projected period is the rising incidence of allergy disorders. There are numerous medications on the market for different kinds of allergies. Allergies can be managed with drugs such as corticosteroids and adrenaline, or simply by avoiding triggers that cause the allergy. In addition to these conventional treatments, several cutting-edge therapies have been developed, such as the use of recombinant allergens and highly purified allergen extracts, which support increased protection against allergies. Additionally, the food business is also adjusting by providing a wide variety of allergy-friendly products. Due to technological developments and an increasing focus on better patient results, the market is expected to grow as governments and healthcare institutions address the difficulties presented by food allergies. Constructive laws and regulations from the government should support market expansion. The US Food and Drug Administration (FDA) is in charge of enforcing laws about processed foods in the country.

Report Coverage

This research report categorizes the market for the food allergy treatment market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the food allergy treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the food allergy treatment market.

Driving Factors

The market for food allergies is a dynamic industry that is expanding significantly as a result of rising worldwide awareness and diagnosis of food allergies. The rise of new markets and greater investment in modern technologies will both benefit the growth of the food allergy sector. Both the understanding of the immunological mechanisms behind allergy illness and the identification of food allergens, which may lead to new therapeutic approaches, have advanced greatly in recent years. Additionally, Improves in medical technology and diagnostic techniques have resulted in more precise and thorough allergy testing. Healthcare providers may now more accurately identify particular allergens because to new and improved allergy testing methods including molecular-based allergy testing and component-resolved diagnostics (CRD).

Restraining Factors

The market may be constrained by technical difficulties related to protein identification, testing, and sampling. Testing for food allergies is a difficult procedure with many technical difficulties.

Market Segmentation

The food allergy treatment market share is classified into allergen type, drug type, route of administration, and end-user.

• The peanuts segment dominates the market with the largest revenue share through the forecast period.

Based on the allergen type, the food allergy treatment market is categorized into dairy products, peanuts, poultry product and, others. Among these, the peanuts segment dominates the market with the largest revenue share through the forecast period. Increasing rates of peanut allergy around the world and a rise in pharmaceutical R&D. Additionally, the market is expected to develop due to the increasing use of novel biological agents to treat allergies and a rise in clinic visits from patients seeking treatment for these allergies.

• The epinephrine is predicted to dominate the food allergy treatment market during the forecast period.

Based on the drug type, the food allergy treatment market is categorized into antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic, immuno-modulators, epinephrine, and others. Among these, the epinephrine is predicted to dominate the food allergy treatment market during the forecast period. The FDA and CDC, among other organizations, advise using epinephrine as the first line of treatment for allergic reactions that are severe. It is anticipated that the release of affordable epinephrine auto-injectors by major players will greatly accelerate market expansion.

• The parenteral segment is anticipated to grow at the fastest CAGR growth through the forecast period.

Based on the route of administration, the food allergy treatment market is categorized into parenteral, oral, and others. Among these, the parenteral segment is anticipated to grow at the fastest CAGR growth through the forecast period. Parenteral route is well-positioned to continue controlling the area. The main drug used to treat anaphylaxis is epinephrine, which is best injected intramuscularly (IM) into the lateral thigh. Intravenous (IV) administration is a possibility, but because it needs to be well monitored, it is usually limited to inpatient settings.

• The hospital pharmacies segment is accounted for the largest market share through the forecast period.

Based on the end-user, the food allergy treatment market is categorized into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is accounted for the largest market share through the forecast period. As many patients who are experiencing an allergic condition's worsening, hospitals serve as their first point of contact. Severe cases frequently require hospitalization and the intravenous (IV) administration of specialist medications under medical care.

Regional Segment Analysis of the Global Food Allergy treatment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the food allergy treatment market over the predicted timeframe.

North America is projected to hold the largest share of the food allergy treatment market over the forecast period. North America leads the food allergy industry since it provides a significant basis for food allergy cases worldwide, a number that is continuously increasing. The need for treatment methods and pharmaceuticals, for example, is increasing due to the rise in food allergies in the region. Because the necessary medical infrastructure is in place to diagnose the illness and offer critical care. Increasingly, research is being done to find better and more efficient treatments for food allergies, which may also lead to increased income. Additionally, rising healthcare costs and the existence of significant important competitors will also accelerate the market's growth.

Asia Pacific is expected to grow at the fastest CAGR growth of the food allergy treatment market during the forecast period. Because of the growing number of generic medicine producers in this area. The region's healthcare infrastructure development and heightened government awareness campaigns will also accelerate the market's growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the food allergy treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• DBV Technologies
• Vedanta Biosciences, Inc.
• Alladapt Immunotherapeutic, Inc.
• Cambridge Allergy Ltd.
• ALS Limited
• Microbac Laboratories
• Neogen Corporation
• AstraZeneca
• Cadila Pharmaceuticals
• Mylan N.V.
• Aravax
• Prota Therapeutics
• Sanofi
• Novartis International AG
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2024, Prominent pharmaceutical company Genentech stated that the U.S. Food and Drug Administration (FDA) had approved their innovative anti-allergy injection, Xolair, for the treatment of severe allergies brought on by exposure to specific foods. Both adults and children over the age of one are permitted to use the medication.

• In May 2023, The New England Journal of Medicine has published the findings of DBV Technologies' Phase 3 EPITOPE research, which involved EPIT using Viaskin Peanut in children between the ages of one and three. This article highlights the possibility of a novel therapeutic approach for this particular age range, providing optimism for the treatment of food allergies in young children.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the food allergy treatment market based on the below-mentioned segments: 

Global Food Allergy Treatment Market, By Allergen Type

• Dairy Products
• Peanuts
• Poultry Product
• Others

Global Food Allergy Treatment Market, By Drug Type

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anti-cholinergic
• Immuno-modulators
• Epinephrine
• Immunotherapy
• Others

Global Food Allergy Treatment Market, By Route of Administration

• Parenteral
• Oral

Global Food Allergy Treatment Market, By End User

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Food Allergy Treatment Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa